Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 1;117(48):30027-30028.
doi: 10.1073/pnas.2011616117. Epub 2020 Nov 12.

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

Xiaoling Xu  1 , Mingfeng Han  2 , Tiantian Li  3 , Wei Sun  2 , Dongsheng Wang  3 , Binqing Fu  4   5 , Yonggang Zhou  4   5 , Xiaohu Zheng  4   5 , Yun Yang  6 , Xiuyong Li  7 , Xiaohua Zhang  2 , Aijun Pan  6 , Haiming Wei  8   5
Affiliations
Comment

Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention

Xiaoling Xu et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Comment on

References

    1. Yang C., Liu E., Liu M., Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients. Proc. Natl. Acad. Sci. U.S.A. 117, 30025–30026 (2020). - PMC - PubMed
    1. Xu X., et al. , Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl. Acad. Sci. U.S.A. 117, 10970–10975 (2020). - PMC - PubMed
    1. Sciascia S., et al. , Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin. Exp. Rheumatol. 38, 529–532 (2020). - PubMed
    1. Alattar R., et al. , Tocilizumab for the treatment of severe coronavirus disease 2019. J. Med. Virol., 92, 2042−2049 (2020). - PMC - PubMed
    1. Russell C. D., Millar J. E., Baillie J. K., Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395, 473–475 (2020). - PMC - PubMed

Substances

LinkOut - more resources